3 completed, 2 not yet recruiting, 1 recruiting. 4 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Not yet recruiting 2 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Carboplatin + Paclitaxel: new trials by email Literature Review of Carboplatin + Paclitaxel trials Research Report on Carboplatin + Paclitaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC Toripalimab, Carboplatin + Paclitaxel - Esophageal Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Vanderbilt-Ingram Cancer Center | 20 | 2026-12-31 | 2026-09-23 |
| Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer Trastuzumab Rezetecan (SHR-A1811), Carboplatin, Bevacizumab - Ovarian Cancer, Platinum Sensitive Ovarian Cancer (PSOC) | Phase 2 | Not yet recruiting | Sun Yat-sen University | 176 | 2026-09-30 | 2026-08-20 |
| Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer medroxyprogesterone acetate tablets OR megestrol acetate, Cisplatin, Carboplatin + Paclitaxel - Endometrial Cancer, Uterine Neoplasms | Phase 3 | Recruiting | University College, London | 600 | 2026-06-29 | 2026-09-21 |
| PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC TAK-676, Carboplatin, 5-FU - Head and Neck Squamous Cell Carcinoma | Early Phase 1 | Completed | Presage Biosciences | 15 | 2021-07-26 | 2023-10-06 |
| Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer Nivolumab, Ipilimumab, Platinum Doublet Chemotherapy - Non-Small-Cell Lung Cancer | Phase 2 | Completed | Bristol-Myers Squibb | 324 | 2016-02-15 | 2023-04-05 |
| Androgen Deprivation Therapy in Advanced Salivary Gland Cancer bicalutamide + triptorelin, Cisplatin + Doxorubicin, Carboplatin + Paclitaxel - Salivary Gland Cancer | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 149 | 2015-09-24 | 2024-11-05 |
Adenocarcinoma (1) · Bulbo-Spinal Atrophy, X-Linked (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Endometrial Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Head and Neck Neoplasms (1) · Ovarian Neoplasms (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Neoplasms (1)
Bristol-Myers Squibb (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Presage Biosciences (1) · Sun Yat-sen University (1) · University College, London (1) · Vanderbilt-Ingram Cancer Center (1)
United States (3) · Austria (1) · Belgium (1) · Canada (1) · China (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Netherlands (1) · United Kingdom (1)
Kevin Harrington (1) · Lisa Licitra (1) · Michael Gibson (1) · Wendy Jenkins (1)